Mylan Pulls Generic Gilenya Application Over Study Concerns

As Accord Withdrawal Of Erlotinib Also Revealed By EMA's CHMP

Tablet
Mylan and Accord will have to resubmit their applications • Source: Shutterstock

More from Generics

More from Products